Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ACTRN12626001144303) titled 'Crohn's Disease Stricture Treatment by Reduction of IL-23 with Guselkumab Versus Optimise Existing Medical Therapy Combined with Endoscopic Dilation (STRIVE) Randomised Controlled Trial' on Sept. 15.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Type of endpoint: Safety/efficacy
Primary Sponsor: Sydney Local Health District
Condition:
Crohn's disease stricture
Crohn's disease stricture
Inflammatory and Immune System - Autoimmune diseases
Oral and Gastrointestinal - Crohn's disease
Intervention:
Participants in the gus...